Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. platoscience

PLATOSCIENCE SIGNED

Personalized Neurostimulation Approach for the Treatment of Depression

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 PLATOSCIENCE project word cloud

Explore the words cloud of the PLATOSCIENCE project. It provides you a very rough idea of what is the project "PLATOSCIENCE" about.

stimulation    conventional    ph1    ph    2015    trans    eeg    25    neuroimaging    until    plug    revenue    depressions    cranial    individual    jobs    start    2026    techniques    people    commercialisation    costing    moderate    first    yields    yielding    customized    profit    benefits    health    rehabilitation    worldwide    programmable    commercialization    headset    cognitive    advantage    consists    setting    nor    acknowledge    personalised    cloud    gross    portable    collection    regulatory    tdcs    home    electroencephalogram    competition    stakeholders    establishing    patients    clinical    patent    clinics    15    medication    standard    measuring    world    patient    predictive    app    acute    electrodes    electrophysiological    subject    introduction    50    segment    despite    professionals    tracked    connected    300    untreated    2005    analytics    million    protected    platoscience    solutions    cumulative    falling    validation    strategy    relevance    sme    direct    options    severe    device    market    hospitals    efficient    18    data    international    170bn    clear    play    depression    online    neurostimulation    group    hereafter    medical    create    platocure    treatment    qualified   

Project "PLATOSCIENCE" data sheet

The following table provides information about the project.

Coordinator		 PLATOSCIENCE APS 

Organization address
address: VESTERBROGADE 26
city: KOBENHAVN
postcode: 1620
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Denmark [DK]
 Project website https://platoscience.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PLATOSCIENCE APS DK (KOBENHAVN) coordinator 50˙000.00

Map

 Project objective

Depression currently affects more than 300 million people worldwide, that is an increase of over 18% between 2005 and 2015. Moreover, 50% of major depressions are untreated in Europe, costing about €170Bn per year. Despite subject´s relevance, there are not any efficient nor customized treatment options, these falling often within conventional solutions (e.g. cognitive techniques), medication or neurostimulation techniques that do not acknowledge an individual rehabilitation for the patient.

Platoscience has developed the world’s first plug n’ play device based on trans-cranial direct current neurostimulation (tDCS) for a personalised at-home treatment of depression. The patent-protected device, PlatoCure, consists of a portable neurostimulation headset with two programmable electrodes, easy to use and control, connected to an app to be tracked by health professionals and for cloud data collection and predictive analytics to improve individual treatment. PlatoCure also includes online neuroimaging by electroencephalogram (EEG) that enables measuring of electrophysiological data during stimulation. This yields a significant advantage of PlatoCure against competition, strengthening market introduction to become the standard treatment device for moderate to severe depression, yielding benefits for a large group of stakeholders, including patients, medical professionals, hospitals and clinics.

The SME Ph1 will be crucial for: i) establishing partnerships with relevant stakeholders on an international level in the medical segment, ii) setting up a regulatory strategy and iii) developing a clear commercialisation strategy. Hereafter, PlatoScience will be able to start SME Ph 2 focusing on the clinical validation of the device with hospitals and clinics. Until the end of 2026, we expect a cumulative revenue of €10,1 million, gross profit of €8,25 million and to create 15 qualified new jobs, within 5 years of commercialization.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLATOSCIENCE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PLATOSCIENCE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More